Digital
The cliff was never the crisis: Pharma’s strategy problem
The patent cliff isn't the problem. It's the symptom.
R&D
Sponsored
What European Commission marketing authorisation of a teripa...
Biosimilars can help support broader patient access while contributing to the long-term sustainability of healthcare systems.
R&D
Why critical-care injectables are among the hardest medicine...
When hospitals in the United States began delaying elective procedures in 2024 over a shortage of intravenous saline solutions, it exposed a structural vulnerability that rarely makes headl
Market Access
Changing Faces: Boards of Directors and Advisory Boards, May...
The latest Board moves reflect a focus on experience in commercialisation, corporate governance, and therapeutic development.
Oncology
Delayed decisions: The patient safety risk hidden inside MDT...
The NHS Cancer Plan has commissioned the Royal College of Radiologists with a formal review of opportunities to modernise Multi-Disciplinary Teams.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
